Mammary Cancer
14
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction
Comparison of ESP and SPSIP Blocks in Breast Surgery
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors
Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point
Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery
Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System
The Effect of a Patient Decision Aids for Breast Cancer Screening
Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors
Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy
Accurate Diagnosis System for Postoperative Chronic Pain Based on fMRI
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy